Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on Dentsply Sirona (XRAY) to $13 from $17 and keeps an In Line rating on the shares as the firm updates estimates and makes several tactical calls in the Healthcare Technology & Distribution group ahead of Q3 earnings season.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- DENTSPLY SIRONA Announces Leadership Transition for Rosenzweig
- Dentsply Sirona appoints Denti as Chief Commercial Officer
- Cautious Hold Rating on DENTSPLY SIRONA Amid Awaited Turnaround Evidence
- DENTSPLY SIRONA Approves Retention Award for Executives
- Hold Rating for DENTSPLY SIRONA Amid Strategic Retention of Wellspect and Focus on Core Dental Business Revitalization